Pioneering scientifically developed biomaterial that efficiently increases dental health

Psilox focus lies on oral care applications, where the unique properties of our proprietary calcium phosphate microspheres can transform many treatments. These microspheres now form the basis of Psilox’s technology platform.

Impact: Improving oral care treatment

Stage: First product is launched in the US and Sweden, a desensitizer gel targeting patients with sensitive teeth, with more products to be rolled out over the coming years.

CEO: Tomas Lindström

GUV Contact: Jesper Dahlberg